Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
Astroblastoma
BRAF mutation
MN1‐BEND2
Next‐generation sequencing
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
24
03
2019
accepted:
21
06
2019
pubmed:
28
7
2019
medline:
2
9
2020
entrez:
27
7
2019
Statut:
ppublish
Résumé
Astroblastoma (ABM) is a rare glial brain tumor. Recurrent meningioma 1 (MN1) alterations have been recently identified in most pediatric cases. Adolescent and adult cases, however, remain molecularly poorly defined. We performed clinical and molecular characterization of a retrospective cohort of 14 adult and 1 adolescent ABM. Strikingly, we found that MN1 fusions are a rare event in this age group (1/15). Using methylation profiling and targeted sequencing, most cases were reclassified as either pleomorphic xanthoastrocytomas (PXA)-like or high-grade glioma (HGG)-like. PXA-like ABM show We suggest that gliomas with astroblastic features include a variety of molecularly sharply defined entities. Adult ABM harboring molecular features of PXA and HGG should be reclassified. Central nervous system high-grade neuroepithelial tumors with Astroblastoma (ABM) remains a poorly defined and controversial entity. Although meningioma 1 alterations seem to define a large subset of pediatric cases, adult cases remain molecularly poorly defined. This comprehensive molecular characterization of 1 adolescent and 14 adult ABM revealed that adult ABM histology comprises several molecularly defined entities, which explains clinical diversity and identifies actionable targets. Namely, pleomorphic xanthoastrocytoma-like ABM cases show a favorable prognosis whereas high-grade glioma (glioblastoma and diffuse midline gliome)-like ABM show significantly worse clinical courses. These results call for in-depth molecular analysis of adult gliomas with astroblastic features for diagnostic and therapeutic purposes.
Sections du résumé
BACKGROUND
Astroblastoma (ABM) is a rare glial brain tumor. Recurrent meningioma 1 (MN1) alterations have been recently identified in most pediatric cases. Adolescent and adult cases, however, remain molecularly poorly defined.
MATERIALS AND METHODS
We performed clinical and molecular characterization of a retrospective cohort of 14 adult and 1 adolescent ABM.
RESULTS
Strikingly, we found that MN1 fusions are a rare event in this age group (1/15). Using methylation profiling and targeted sequencing, most cases were reclassified as either pleomorphic xanthoastrocytomas (PXA)-like or high-grade glioma (HGG)-like. PXA-like ABM show
CONCLUSION
We suggest that gliomas with astroblastic features include a variety of molecularly sharply defined entities. Adult ABM harboring molecular features of PXA and HGG should be reclassified. Central nervous system high-grade neuroepithelial tumors with
IMPLICATIONS FOR PRACTICE
Astroblastoma (ABM) remains a poorly defined and controversial entity. Although meningioma 1 alterations seem to define a large subset of pediatric cases, adult cases remain molecularly poorly defined. This comprehensive molecular characterization of 1 adolescent and 14 adult ABM revealed that adult ABM histology comprises several molecularly defined entities, which explains clinical diversity and identifies actionable targets. Namely, pleomorphic xanthoastrocytoma-like ABM cases show a favorable prognosis whereas high-grade glioma (glioblastoma and diffuse midline gliome)-like ABM show significantly worse clinical courses. These results call for in-depth molecular analysis of adult gliomas with astroblastic features for diagnostic and therapeutic purposes.
Identifiants
pubmed: 31346129
pii: theoncologist.2019-0223
doi: 10.1634/theoncologist.2019-0223
pmc: PMC6975955
doi:
Substances chimiques
Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1584-1592Informations de copyright
© AlphaMed Press 2019.
Déclaration de conflit d'intérêts
Disclosures of potential conflicts of interest may be found at the end of this article.
Références
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Onco Targets Ther. 2015 Feb 19;8:451-60
pubmed: 25737639
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
J Clin Neurosci. 2011 Jun;18(6):750-4
pubmed: 21507653
J Neurooncol. 2009 Jul;93(3):369-78
pubmed: 19214707
Stem Cell Reports. 2015 Dec 8;5(6):946-953
pubmed: 26584541
Nature. 2014 Feb 27;506(7489):451-5
pubmed: 24553141
Acta Neuropathol. 2018 Nov;136(5):805-810
pubmed: 30259105
CNS Oncol. 2018 Apr;7(2):CNS13
pubmed: 29708401
Neuro Oncol. 2017 Jan;19(1):31-42
pubmed: 27416954
Cancer. 1999 May 1;85(9):2033-45
pubmed: 10223246
World Neurosurg. 2014 Jul-Aug;82(1-2):e291-7
pubmed: 24141003
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Bioinformatics. 2012 Aug 15;28(16):2184-5
pubmed: 22743226
Cell. 2016 Feb 25;164(5):1060-1072
pubmed: 26919435
Genome Biol. 2013 Feb 14;14(2):R12
pubmed: 23409703
Acta Neuropathol. 2013 Dec;126(6):907-15
pubmed: 24154961
Nat Biotechnol. 2016 Feb;34(2):155-63
pubmed: 26619011
Clin Cancer Res. 2015 Jul 15;21(14):3307-17
pubmed: 25609060
Brain Pathol. 2014 Apr;24(3):221-9
pubmed: 24345274
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Genet. 2013 Aug;45(8):927-32
pubmed: 23817572
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Neuropathology. 2015 Aug;35(4):303-11
pubmed: 25786545
Brain Pathol. 2019 Jan;29(1):85-96
pubmed: 30051528
Acta Neuropathol. 2018 Nov;136(5):793-803
pubmed: 30187121
Acta Neuropathol Commun. 2019 Mar 15;7(1):42
pubmed: 30876455
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Cancer Genet. 2016 Jul-Aug;209(7-8):321-30
pubmed: 27425854
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Bioinformatics. 2016 Apr 15;32(8):1226-8
pubmed: 26656567
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
AJNR Am J Neuroradiol. 2002 Feb;23(2):243-7
pubmed: 11847049
Brain Pathol. 2018 Sep;28(5):684-694
pubmed: 28990708
Genome Med. 2015 May 11;7(1):43
pubmed: 26019724
Genome Biol. 2011 Aug 11;12(8):R72
pubmed: 21835007
Brain Pathol. 2016 Sep;26(5):569-80
pubmed: 26517431
Brain Pathol. 2018 Mar;28(2):192-202
pubmed: 28960623
Bioinformatics. 2014 Sep 15;30(18):2678-80
pubmed: 24876377
Cancer Cell. 2015 Sep 14;28(3):370-83
pubmed: 26343582
Childs Nerv Syst. 2017 Aug;33(8):1295-1302
pubmed: 28477040
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Neuroradiology. 2007 Mar;49(3):203-9
pubmed: 17216265
Brain Pathol. 2000 Jul;10(3):342-52
pubmed: 10885653
Nature. 2017 Aug 10;548(7666):234-238
pubmed: 28783719
PLoS Comput Biol. 2011 May;7(5):e1001138
pubmed: 21625565